Every
The EVERY Company produces animal-free proteins via fermentation, including its flagship egg-alternative, OvoPro™, which functions like traditional egg whites.
Secondary Market Price
How Every Measures Up
To help you manage your Every equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series D
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Every's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Every Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Every's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
The EVERY Company uses fermentation to produce animal-free proteins that are designed to taste and function like their animal-based counterparts. The company supplies these proteins to the food and beverage industry for use in applications ranging from bakery and beverages to alternative meats. Its primary product is OvoPro™, a shelf-stable powder that serves as an egg and egg white replacer. Founded in 2014 by Co-Founder and CEO Arturo Elizondo, the company has grown from a startup to a commercial supplier whose ingredients are used in products sold at major retailers, including Walmart and Target.
The company is currently focused on scaling its manufacturing and distribution. Two months ago, it announced it had raised $55 million in Series D financing to expand its manufacturing footprint and supply major multinational customers. This follows a recent announcement that products containing its OvoPro™ ingredient have launched in Target stores nationwide, adding to its existing retail presence. The company's stated mission is to decouple protein production from animals to improve the resilience of the global food system.
- McWin Capital Partners
- Main Sequence
- Bloom8
- TO.VC
- Minerva Foods
- Grosvenor Food & Ag
- New Agrarian
- SOSV
- Prosus Ventures
- Rage Capital
- Temasek
- Wheatsheaf Group
- TO Ventures
- Co-Founder, Arturo Elizondo
- Co-Founder, David Anchel
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Every worth joining?
Deciding whether to join a startup like Every involves evaluating the total compensation package, including the potential future value of your equity. Tools like Prospect can help you analyze the equity portion of your offer by using data-driven models to project a company's future value.
What should I do with my Every stock?
The right strategy for your Every stock depends on your personal financial goals, tax situation, and risk tolerance. Platforms like Prospect build customized, multi-year strategies for exercising options and selling shares to help you maximize your returns.
Can you sell Every stock?
As a private company, selling Every stock is generally restricted and only possible during specific liquidity events like tender offers, secondary sales, or an IPO. When these opportunities occur, tools from Prospect can help you determine which shares are the most tax-efficient to sell.
How can I find the value of my Every stock?
Valuing stock in a private company is challenging because it isn’t publicly traded, but you can use the company's 409A valuation as a baseline. For a more comprehensive forecast, Prospect uses predictive models and investor-grade data to project the future value of your shares.
What is Every's equity worth?
The precise worth of equity in a private company like Every is difficult to determine until a liquidity event like an IPO. You can use services like Prospect to get a data-driven projection of your equity's potential future value based on proprietary models.
What is Every's stock ticker symbol?
As a private, pre-IPO company, Every does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they become publicly traded on a stock exchange.
Can I buy or sell Every stock?
You can typically "buy" stock by exercising your vested options, but selling shares of a private company like Every is restricted to specific events like tender offers. Platforms like Prospect provide personalized, tax-optimized strategies for both exercising options and selling shares when opportunities arise.
What is the criteria to buy or invest in Every stock?
Investing in a private startup like Every is typically limited to employees receiving equity compensation or accredited investors participating in private funding rounds. General investment from the public is not possible until the company has an IPO.
